Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis

Journal of the American Society of Nephrology

Volumn 21, Issue 12, 2010, Pages 2169-2179

  Berden, Annelies E ^a   Nolan, Sarah L ^b   Morris, Hannah L ^b   Bertina, Rogier M ^a   Erasmus, Dianhdra D ^a   Hagen, E Christiaan ^c   Hayes, Donal P ^c   Van Tilburg, Nico H ^a   Bruijn, Jan A ^a   Savage, Caroline O S ^b   Bajema, Ingeborg M ^a   Hewins, Peter ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; PLASMIN; PLASMINOGEN ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY NECROSIS; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 78649853536     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010030274     Document Type: Article

References (41)

1. Jennette JC, Falk RJ: New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 20: 55-60, 2008
2. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
3. Bautz DJ, Preston GA, Lionaki S, Hewins P, Wolberg AS, Yang JJ, Hogan SL, Chin H, Moll S, Jennette JC, Falk RJ: Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 19: 2421-2429, 2008
4. Heeringa P, Tervaert JW: Pathophysiology of ANCA-associated vasculitides: Are ANCA really pathogenic? Kidney Int 65: 1564-1567, 2004
5. Novak RF, Christiansen RG, Sorensen ET: The acute vasculitis of Wegener's granulomatosis in renal biopsies. Am J Clin Pathol 78: 367-371, 1982
6. Collen A: Fibrin Matrix Structure and Angiogenesis [PhD thesis], Leiden, The Netherlands, Leiden University, 2000
7. Hertig A, Rondeau E: Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 15: 844-853, 2004 (Pubitemid 38375303)
8. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185: 963-968, 1997
9. Lin WS, Chen PC, Yang CD, Cho E, Hahn BH, Grossman J, Hwang KK, Chen PP: Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum 56: 1638-1647, 2007
10. Levey AS, Greene T, Kusek JW, G.J.B: A simplified equation to predict glomerular filtration rate from serum creatinine. [Abstract]. J Am Soc Nephrol 11: 155A, 2000
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
12. Chen XX, Gu YY, Li SJ, Qian J, Hwang KK, Chen PP, Chen SL, Yang CD: Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice. J Immunol 178: 5351-5356, 2007
13. Lu CS, Horizon AA, Hwang KK, FitzGerald J, Lin WS, Hahn BH, Wallace DJ, Metzger AL, Weisman MH, Chen PP: Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum 52: 4018-4027, 2005
14. Yang CD, Hwang KK, Yan W, Gallagher K, FitzGerald J, Grossman JM, Hahn BH, Chen PP: Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol 172: 5765-5773, 2004
15. Cugno M, Cabibbe M, Galli M, Meroni PL, Caccia S, Russo R, Bottasso B, Mannucci PM: Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 103: 2121-2126, 2004
16. Sebastian JK, Voetsch B, Stone JH, Romay-Penabad Z, Lo GH, Allen NB, Davis JC, Jr., Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Loscalzo J, Pierangeli S, Merkel PA: The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol 34: 2446-2450, 2007
17. Tomasson G, Monach PA, Merkel PA: Thromboembolic disease in vasculitis. Curr Opin Rheumatol 21: 41-46, 2009
18. Jennette JC, Charles LA, Falk RJ: Antineutrophil cytoplasmic autoantibodies: Disease associations, molecular biology, and pathophysiology. Int Rev Exp Pathol 32: 193-221, 1991
19. Jennette JC: Antineutrophil cytoplasmic autoantibody-associated diseases: A pathologist's perspective. Am J Kidney Dis 18: 164-170, 1991
20. Bajema IM, Bruijn JA: What stuff is this! A historical perspective on fibrinoid necrosis. J Pathol 191: 235-238, 2000
21. Bajema IM: Aspects of ANCA-Associated Glomerulonephritis. PhD Thesis, Leiden, The Netherlands, Leiden University, 2000
22. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135: 921-930, 1989
23. Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, Williams DG, Taube D, Brown CB, Hicks JA: Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome. Q J Med 53: 181-207, 1984
24. Channing AA, Kasuga T, Horowitz RE, Dubois EL, Demopoulos HB: An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse. Am J Pathol 47: 677-694, 1965
25. Silva FG, Hoyer JR, Pirani CL: Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors. Lab Invest 51: 404-415, 1984
26. Vassalli P, McCluskey RT: The pathogenic role of the coagulation process in rabbit masugi nephritis. Am J Pathol 45: 653-677, 1964
27. Naish P, Penn GB, Evans DJ, Peters DK: The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 42: 643-646, 1972
28. Thomson NM, Simpson IJ, Peters DK: A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol 19: 301-308, 1975
29. Thomson NM, Moran J, Simpson IJ, Peters DK: Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int 10: 343-347, 1976
30. Crummy CS, Perlin E, Moquin RB: Microangiopathic hemolytic anemia in Wegener's granulomatosis. Am J Med 51: 544-548, 1971
31. Juncos LI, Alexander RW, Marbury TC: Intravascular clotting preceding crescent formation in a patient with Wegener's granulomatosis and rapidly progressive glomerulonephritis. Nephron 24: 17-20, 1979
32. Fuller T, Olsen N, Block A, Cade J: Wegener's granulomatosis. Treatment with heparin in addition to azathioprine and corticosteroids. Nephron 9: 225-234, 1972
33. Whitaker AN, Emmerson BT, Bunce IH, Nicoll P, Sands JM: Reversal of renal failure in Wegener's granulomatosis by heparin. Am J Med Sci 265: 399-406, 1973
34. Frasca GM, Zoumparidis NG, Borgnino LC, Neri L, Neri L, Vangelista A, Bonomini V: Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis - Clinical course and long-term outcome. Int J Artif Organs 16: 11-19, 1993
35. Zoja C, Corna D, Macconi D, Zilio P, Bertani T, Remuzzi G: Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis. Lab Invest 62: 34-40, 1990
36. Tipping PG, Holdsworth SR: Fibrinolytic therapy with streptokinase for established experimental glomerulonephritis. Nephron 43: 258-264, 1986
37. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
38. Williams JM, Pettitt TR, Powell W, Grove J, Savage CO, Wakelam MJ: Antineutrophil cytoplasm antibody-stimulated neutrophil adhesion depends on diacylglycerol kinase-catalyzed phosphatidic acid formation. J Am Soc Nephrol 18: 1112-1120, 2007 (Pubitemid 46536897)
39. de Lind van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Gaskin G, Rasmussen N, Noel LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM, for the European Vasculitis Study Group (EUVAS): Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17: 2264-2274, 2006
40. Senn S, Stevens L, Chaturvedi N: Repeated measures in clinical trials: Simple strategies for analysis using summary measures. Stat Med 19: 861-877, 2000
41. Bajema IM, Hagen EC, Hansen BE, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: The renal histopathology in systemic vasculitis: An international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 11: 1989-1995, 1996